Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

The Invesco Pharmaceuticals ETF (PJP) is a passively managed fund tracking the Dynamic Pharmaceutical Intellidex Index with $541.13 million in assets. It offers broad exposure to U.S. pharmaceutical companies with a 0.57% expense ratio and 0.82% dividend yield. The ETF has gained 24.96% year-to-date and 41.74% over the past year but carries higher risk with a beta of 0.45 and 16.02% standard deviation. It holds 32 stocks with top positions in Abbott Laboratories, Amgen, and Abbvie, and carries a Zacks ETF Rank of 3 (Hold).